Sobeh, Mohammed S., Chan, P., Greenwald, Stephen E., Ham, Robert J., Wood, Alan J., Cross, Frank W., Hsiang, York N. (1994) Suppression of neointimal hyperplasia by photodynamic therapy: in vitro and in vivo results. In: Proceedings of Diagnostic and Therapeutic Cardiovascular Interventions IV. Diagnostic and Therapeutic Cardiovascular Interventions IV. . pp. 47-52. SPIE (doi:10.1117/12.179929) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:78349)
The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. | |
Official URL: https://doi.org/10.1117/12.179929 |
Abstract
Proliferation of vascular smooth muscle cells (VSMCs) is the pathophysiogical basis of the restenoses which occur in 30-55% of patients undergone revascularisation. Prophylactic measures including pharmacotherapy, endovascular stenting and anti-gene therapy have so far failed to contain this problem. Photodynamic therapy (PDT) may selectively suppress VSMCs and decrease restenosis rates. We report 2 studies; the first examines the effect of PDT on an in-vitro model of NIH and the second involves using endoluminal ablation of an in-vivo model of experimental NIH of the rabbit's aorta.
Item Type: | Conference or workshop item (Proceeding) |
---|---|
DOI/Identification number: | 10.1117/12.179929 |
Uncontrolled keywords: | Blood vessels, Cardiovascular system, Cells, Muscle, Atherosclerosis, Neointimal hyperplasia, Restenosis, Revascularization, Vascular smooth muscle cells, Photodynamic therapy |
Divisions: | Divisions > Division of Natural Sciences > Kent and Medway Medical School |
Depositing User: | Philip Chan |
Date Deposited: | 07 Nov 2019 16:58 UTC |
Last Modified: | 05 Nov 2024 12:43 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/78349 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):